ABCC5 and posterior cortical atrophy: The results showed that treatment with Asatone in stable ABCC5-depleted enzalutamide-resistant PCa cells rescued ABCC5 knockdown-induced resensitization toward enzalutamide and markedly promoted the proliferation ability of the ABCC5-depleted group compared to that of the control group (Fig. 6D).